| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 1st July 2020 | David Francis Carroll | 7,500 | Exercise of derivative | $0.00 | |
| 19th June 2020 | Venture Capital Iv, L.P. Versant | 3,428,221 | Other acquisition or disposition | $0.00 | |
| 19th June 2020 | Venture Capital Iv, L.P. Versant | 34,282 | Other acquisition or disposition | $0.00 | |
| 19th June 2020 | Venture Capital Iv, L.P. Versant | 34,282 | Other acquisition or disposition | $0.00 | |
| 19th June 2020 | Venture Capital Iv, L.P. Versant | 21,597 | Other acquisition or disposition | $0.00 | |
| 4th June 2020 | Glenn Sblendorio | 5,855 | Grant/award etc. | $0.00 | |
| 28th May 2020 | Glenn Sblendorio | 1,595 | Grant/award etc. | $0.00 | |
| 1st April 2020 | Glenn Sblendorio | 18,750 | Exercise of derivative | $0.00 | |
| 6th January 2020 | David R Guyer | 3,367 | Open or private sale | $8.07 | $27,171.69 |
| 6th January 2020 | Keith Westby | 293 | Open or private sale | $8.07 | $2,364.51 |
Iveric Bio
The company is developing novel therapeutics to treat diseases of the eye. The company is based in San Francisco and has offices in New York and London.
Ticker: OPHT
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1410939
Employees:
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Cash at Carrying Value: $108 M (0%)
Assets, Current: $115 M (-10%)
Property, Plant and Equipment, Net: $135 Th (-21%)
Other Assets, Noncurrent: $12 Th (0%)
Assets: $116 M (-11%)
Liabilities, Current: $11 M (-15%)
Liabilities: $11 M (-14%)
Common Stock, Value, Issued: $50 Th (0%)
Common Stock, Shares, Issued: $50 M (0%)
Retained Earnings (Accumulated Deficit): $496 M (3%)
Stockholders' Equity (Parent): $105 M (0%)
Liabilities and Equity: $116 M (-11%)
Research and Development: $14 M (78%)
General and Administrative Expenses: $5 M (-8%)
Operating Income/Loss: $19 M (42%)
Provision for income taxes: $3 M (0%)
News
What Makes James Bond Great
31st October 2020
Top Stocks To Short As Markets Look To End Month With Losses
31st October 2020
Behind real estate’s surprise 2020 boom and what comes next
31st October 2020
Dunkin' Brands to go private in US$8.76 billion deal by Arby's owner
31st October 2020